Patra NeurosurgicalPatient education

Procedure

Deep brain stimulation (DBS) for movement disorders

Thin wires placed deep in the brain send mild electrical pulses to ease movement symptoms. It is for selected people with Parkinson's disease or essential tremor.

How this page was written
Compiled from the sources cited on the page, with AI drafting assistance
Clinical review
Not individually reviewed by a clinician. How pages are written
Last updated
November 17, 2026

General information, not medical advice. In an emergency call 911. Full disclaimer

What it does

DBS places thin wires (leads) in a small target deep in the brain. They connect under the skin to a pulse generator, like a pacemaker, below the collarbone. The pulses block signals that cause symptoms. [1]

The targets, in plain words. The FDA has approved 3 targets. [2]

DBS for epilepsy is different. It uses another part of the thalamus (the anterior nucleus). The goal is fewer seizures. In a trial of 110 adults, seizures fell by about half (median 56%) by 2 years. Few became seizure free. [5] See DBS for epilepsy.

When it is considered

What matters most in the decision

Set goals for each symptom. DBS mainly helps movement. In Parkinson's disease, it can help tremor, stiffness, slowness, "off" time, and dyskinesia. It does not usually help speech, freezing, balance, mood, or memory. [7] [2] [8] For essential tremor, the goal is less hand and arm tremor. [6]

Surgery risk is higher after age 70 and with high blood pressure or blood vessel disease in the brain. [9]

Preparation and what happens

Expected benefits

The first 3 trials studied people with Parkinson's disease.

Risks and complications

Serious or lasting risks

Effects that may come and go

Limits of the evidence. A 2024 review of 7 trials rated the evidence as very low certainty. DBS raised serious adverse events, mainly from surgery and hardware. [14]

Battery and device care. A standard battery lasts about 3 to 5 years. A rechargeable one lasts about 9 years. A failed battery must be replaced. Parts can break or move. [1]

MRI cautions. Some devices allow MRI only under certain conditions. A device with unknown MRI safety should be treated as unsafe. Always tell the MRI staff you have a DBS system. [15]

Alternatives

Recovery and follow-up

Programming. The device is usually turned on a few weeks after surgery. Programming finds settings that help symptoms with few side effects. Some centers schedule visits every 1 to 2 months for the first 6 months. Later, many people need 1 or 2 visits a year. [2] Most people still take medicine, often at a lower dose. [1]

Call your surgeon for fever, redness at a cut, new weakness, or speech or vision trouble. [1] Any change in your medicine should come from your treating team. Recovery varies. Follow the discharge instructions from your own team.

Questions to ask

  1. Which of my symptoms should DBS help, and which not?
  2. Which target do you suggest for me, and why?
  3. How many programming visits will I need?
  4. Should I choose a rechargeable battery, and can I have MRI scans later?

Sources

  1. Deep brain stimulation. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Published October 27, 2025. Open source
  2. Deep Brain Stimulation. Parkinson's Foundation. Open source
  3. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010;362(22):2077-2091. Published June 3, 2010. Open source
  4. Essential Tremor. National Institute of Neurological Disorders and Stroke (NINDS). Open source
  5. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908. Published March 17, 2010. Open source
  6. Premarket Approval P960009: Medtronic Activa Tremor Control System. US Food and Drug Administration. Published July 31, 1997. Open source
  7. Parkinson's Disease. National Institute of Neurological Disorders and Stroke (NINDS). Open source
  8. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63-73. Published January 7, 2009. Open source
  9. Deep Brain Stimulation. American Association of Neurological Surgeons (AANS). Published April 15, 2024. Open source
  10. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896-908. Published August 31, 2006. Open source
  11. Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013;368(7):610-622. Published February 14, 2013. Open source
  12. Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000;342(7):461-468. Published February 17, 2000. Open source
  13. Rasiah NP, Maheshwary R, Kwon CS, Bloomstein JD, Girgis F. Complications of deep brain stimulation for Parkinson disease and relationship between micro-electrode tracks and hemorrhage: systematic review and meta-analysis. World Neurosurg. 2023;171:e8-e23. Published October 13, 2022. Open source
  14. Petersen JJ, Kamp CB, Faltermeier P, et al. Deep brain stimulation for Parkinson's disease: systematic review with meta-analysis and trial sequential analysis. BMJ Med. 2024;3(1):e000705. Published August 16, 2024. Open source
  15. MRI (Magnetic Resonance Imaging): Benefits and Risks. US Food and Drug Administration. Open source
  16. Parkinson disease. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Published January 27, 2026. Open source
  17. FDA Approves Insightec Exablate Neuro to Treat Second Side of Essential Tremor. NeurologyLive. December 21, 2022. Published December 21, 2022. Open source